antiplatelet Flashcards

1
Q

What are the 3 ways of using drugs to achieve anti-clotting

A

anti platelet drug

anti coagulant drug

thrombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does prostacyclin result in antiplatelet effect

A

prostacyclin binds to platelet membrane receptors causing synthesis of cAMP, cAMP inhibits release of granules containing aggregating agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what does the aggregating agents include

A

serotonin and ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does thromboxane A2 cause platelets to aggregate

A

thromboxane A2 and exposed collagen cause the release of AA from the platelet membrane. TXA2 is synthesized from AA and released from platelet. TXA 2 binds to receptors on other platelets thereby initiating release of additional aggregating agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pathway of AA synthesizing more TXA2 inhibited by

A

aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some examples of anti-platelet drugs

A
  1. platelet GP2B/3A receptor blocker
  2. NSAIDS
  3. ADP receptor blockers
  4. PDE inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is NSAIDS like aspirin used for clinically

A

a. prophylactic treatment of transient cerebral ischemia

  1. reduce incidence of recurrent myocardial infarction
  2. decrease mortality of postmyocardial infarction patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the adverse effect of NSAIDS

A

bleeding (PGI2)

gastric upset and ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the GP2B/3A receptor

A

It is a platelet membrane surface protein, activation of receptor complex is the final common pathway for platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does GP2B/3A receptor result in platelet aggregating effect

A

Receptor complex anchor on fibrinogen allowing crosslinking to become fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some example of GP2B/3A receptor blocker drugs

A

Epitifibatide
-mediates binding of fibrinogen to receptor

Abciximab
- is a monoclonal antibody, taken IV, reversibily inhibit binding of fibrinogen and other ligands to the 2B/3A receptor

Tirofiban
- taken orally, small molecule blocker of 2B/3A receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some example of ADP receptor blockers

A

Clopidogrel, Ticlopidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does PDE inhibitor help with anti-platelet

A

Prevents cAMP from degradation. cAMP inhibits degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does PDE inhibitor help with anti-platelet

A

Prevents cAMP from degradation. cAMP inhibits degranulation, lesser aggregating agents produced, resulting in antiplatelet effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is an example of a PDE inhibitor

A

Dipyridamole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some examples of anticoagulant drugs

A

warfarin, heparin

16
Q

What is heparin

A

a family of sulfated glycosaminoglycans

17
Q

how does heparin work

A

○ Active heparin molecules bind tightly to AT3 and cause a conformational change which exposes its active site for more rapid interaction with the proteases
○ To inhibit thrombin, necessary for heparin to bind to enzyme and AT3. Where as for factor 10 it is only necessary to bind to AT3
○ LMWH increase action of AT3 on factor 10a, but not action on thrombin. Because LMWH cannot allow binding of AT3 and thrombin together

18
Q

what are the clinical uses of heparin

A

○ Treat deep vein thrombosis, pulmonary embolism, acute myocardial infarction
○ Used in combination with thrombolytics for revascularisation and in combination with GPIIb/IIIa inhibitors during angioplasty and placement of coronary stents
Can be used in pregnancy if really bobian

19
Q

what would happen if heparin is given intramuscularly

A

hematoma

20
Q

What are the adverse effect of heparin

A

haemorrhage, thrombosis and thrombocytopenia

21
Q

how is vitamin K important in the coagulation pathway

A

reduced vitamin K is an essential cofactor in gamma carboxylation of glutamate residues found in factor 2,7,9,10

22
Q

What is vitamin K used for clinically

A

used to treat and prevent bleeding resulting from the use of anticoagulant drugs like warfarin

for babies to prevent haemorrhagic disease

for vit K deficiencies in adults

23
Q

What does warfarin do

A

inhibit vitamin K reductase, inhibits quinone( oxidised form of Vit K) from reducing to hydroquinone ( the reduced form of Vit K). without hydroquinone, y- carboxylation of glutamate residues cannot occur, thrombin and other coagulation pathway is limited

24
Q

What are the adverse effect of warfarin

A

bleeding,,, warfarin crosses placenta readily, can cause hemorrhagic disorder in the fetus,,, fetal proteins with gamma carboxyglutamate residues found in bone and blood may be affected by warfarin

drug interaction that affect availability of cy450 can affect how much warfarin get metabolised and eliminated

25
Q

What are the pharmacokinetics of warfarin

A

warfarin given orally absorbed quickly and totally

small distribution volume as it is strongly bounded to albumin

elimination depends on metabolism by hepatic cytochrome p450

26
Q

what can increase cyp450

A

barbiturates, carbamezepine, phenytoin increase cyp450, can result in underdosing of warfarin

27
Q

what can decrease cyp450

A

amiodarone, cimetidine, disulfiram, imipramine

28
Q

What are the 4 main type of thrombolytic agents

A

t-pa, urokinase, streptokinase, antistreplase

29
Q

what does thrombolytic agents do

A

activate plasminogen to form plasmin. Plasmin tries to break down fibrin into fibrin degradation products

30
Q

what are the clinical uses of anti-thrombotic agents

A

emergency treatment of coronary artery thrombosis, peripheral arterial thrombosis and emboli, ischaemic stroke